96 related articles for article (PubMed ID: 2482482)
21. Significant high expression of cytokeratins 7, 8, 18, 19 in pulmonary large cell neuroendocrine carcinomas, compared to small cell lung carcinomas.
Nagashio R; Sato Y; Matsumoto T; Kageyama T; Satoh Y; Ryuge S; Masuda N; Jiang SX; Okayasu I
Pathol Int; 2010 Feb; 60(2):71-7. PubMed ID: 20398190
[TBL] [Abstract][Full Text] [Related]
22. [Bronchial carcinoid and small cell lung cancer--neuroendocrine tumors. Immunohistochemical studies].
Maryniak R; Nasierowska A
Pneumonol Pol; 1989; 57(10-12):489-95. PubMed ID: 2561612
[TBL] [Abstract][Full Text] [Related]
23. Coexpression of neuroendocrine markers and epithelial cytoskeletal proteins in bronchopulmonary neuroendocrine neoplasms.
Blobel GA; Gould VE; Moll R; Lee I; Huszar M; Geiger B; Franke WW
Lab Invest; 1985 Jan; 52(1):39-51. PubMed ID: 2981372
[TBL] [Abstract][Full Text] [Related]
24. Spontaneous changes in intermediate filament protein expression patterns in lung cancer cell lines.
Broers JL; Rot MK; Oostendorp T; Bepler G; De Leij L; Carney DN; Vooijs GP; Ramaekers FC
J Cell Sci; 1988 Sep; 91 ( Pt 1)():91-108. PubMed ID: 2473086
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of intermediate filament proteins distinguishes classic from variant small-cell lung cancer cell lines.
Broers JL; Carney DN; de Ley L; Vooijs GP; Ramaekers FC
Proc Natl Acad Sci U S A; 1985 Jul; 82(13):4409-13. PubMed ID: 2409557
[TBL] [Abstract][Full Text] [Related]
26. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
[TBL] [Abstract][Full Text] [Related]
27. NSP-encoded reticulons are neuroendocrine markers of a novel category in human lung cancer diagnosis.
van de Velde HJ; Senden NH; Roskams TA; Broers JL; Ramaekers FC; Roebroek AJ; Van de Ven WJ
Cancer Res; 1994 Sep; 54(17):4769-76. PubMed ID: 8062278
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical distinction between merkel cell carcinoma and small cell carcinoma of the lung.
Bobos M; Hytiroglou P; Kostopoulos I; Karkavelas G; Papadimitriou CS
Am J Dermatopathol; 2006 Apr; 28(2):99-104. PubMed ID: 16625069
[TBL] [Abstract][Full Text] [Related]
29. Varying expression of cytokeratin and neurofilaments in neuroendocrine tumors of human gastrointestinal tract.
Miettinen M; Lehto VP; Dahl D; Virtanen I
Lab Invest; 1985 Apr; 52(4):429-36. PubMed ID: 2580121
[TBL] [Abstract][Full Text] [Related]
30. Coexpression of cytokeratins 7 and 20 confirms urothelial carcinoma presenting as an intrarenal tumor.
Han AC; Duszak R
Cancer; 1999 Dec; 86(11):2327-30. PubMed ID: 10590374
[TBL] [Abstract][Full Text] [Related]
31. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases.
Chu P; Wu E; Weiss LM
Mod Pathol; 2000 Sep; 13(9):962-72. PubMed ID: 11007036
[TBL] [Abstract][Full Text] [Related]
32. Identification of cytoskeletal structures in hormone producing lung cancer cell cultures.
Broers JL; Gropp C; Bepler G; Rot MK; Beck J; Schaart G; Vooijs GP; Ramaekers FC
Acta Histochem Suppl; 1987; 34():57-75. PubMed ID: 2437618
[TBL] [Abstract][Full Text] [Related]
33. [Immunohistochemical study on keratin no. 8, 18 and 19 expression of carcinoid tumors].
Yuminamochi T; Ishii Y; Nakazawa K; Hosogaya S; Ozaki Y; Suda K; Kume S
Rinsho Byori; 1998 Feb; 46(2):163-7. PubMed ID: 9528341
[TBL] [Abstract][Full Text] [Related]
34. [Intermediate filament proteins as markers in tumor diagnosis].
Altmannsberger M
Veroff Pathol; 1988; 127():1-105. PubMed ID: 3341148
[TBL] [Abstract][Full Text] [Related]
35. Expression of cytokeratin and neuron-specific enolase in small cell carcinomas of the lung.
Kitinya JN; Kingo M; Tanaka K
Histol Histopathol; 1987 Oct; 2(4):333-43. PubMed ID: 2485219
[TBL] [Abstract][Full Text] [Related]
36. Expression of nicotinic receptors in normal and tumoral pulmonary neuroendocrine cells (PNEC).
Sartelet H; Maouche K; Totobenazara JL; Petit J; Burlet H; Monteau M; Tournier JM; Birembaut P
Pathol Res Pract; 2008; 204(12):891-8. PubMed ID: 18667281
[TBL] [Abstract][Full Text] [Related]
37. Neurofilament immunoreactivity in Merkel-cell tumors: a differentiating feature from small-cell carcinoma.
Shah IA; Netto D; Schlageter MO; Muth C; Fox I; Manne RK
Mod Pathol; 1993 Jan; 6(1):3-9. PubMed ID: 7678934
[TBL] [Abstract][Full Text] [Related]
38. Biology and novel therapeutics for neuroendocrine tumors of the lung.
Jafri N; Salgia R
J Biol Regul Homeost Agents; 2004; 18(3-4):275-90. PubMed ID: 15786694
[TBL] [Abstract][Full Text] [Related]
39. Synaptophysin and neurofilament proteins as markers for neuroendocrine tumors.
Miettinen M
Arch Pathol Lab Med; 1987 Sep; 111(9):813-8. PubMed ID: 2820344
[TBL] [Abstract][Full Text] [Related]
40. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors.
Cai YC; Banner B; Glickman J; Odze RD
Hum Pathol; 2001 Oct; 32(10):1087-93. PubMed ID: 11679943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]